Antithrombin III: no benefit in severe sepsis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1311, 2001-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunopathogenesis of severe sepsis

By Noursadeghi Mahdad Cohen Jonathan

Clinical Medicine, Vol. 34, Iss. 5, 2000-09 ,pp. : 432-436

Royal College Of Physicians

Access to resources Recommend Favorite

Recombinant Human Antithrombin III: rhATIII

By Adis International Limited

Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. : 110-112

Adis International

Access to resources Recommend Favorite

Antithrombotic agents in the treatment of severe sepsis

By Shadid Hazar Aziz Salim Ahmad Sarfraz Fareed Jawed Hoppensteadt Debra Messmore Harry Wehrmacher William Tobu Mahmut Iqbal Omer

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 1, 2002-05 ,pp. : 111-139

Informa Healthcare

Access to resources Recommend Favorite

Presentation and clinical features of severe sepsis

By Green Justin Lynn William A

Clinical Medicine, Vol. 34, Iss. 5, 2000-09 ,pp. : 418-423

Royal College Of Physicians

Access to resources Recommend Favorite

Haemodynamic and ventilatory support in severe sepsis

By Callister Matthew E. J. Evans Timothy W

Clinical Medicine, Vol. 34, Iss. 6, 2000-11 ,pp. : 522-528

Royal College Of Physicians

Access to resources Recommend Favorite